FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

702836004: Trastuzumab emtansine (substance)

Status: current, Primitive. Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006212012 Trastuzumab emtansine en Synonym Active Case insensitive SNOMED CT core
3006214013 Trastuzumab emtansine (substance) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab emtansine Is a Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab emtansine Has disposition Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab emtansine Is a Murine-human monoclonal IgG antibody false Inferred relationship Some
Trastuzumab emtansine Is a Antineoplastic agent false Inferred relationship Some
Trastuzumab emtansine Is modification of Trastuzumab false Inferred relationship Some
Trastuzumab emtansine Is a Enzyme inhibitor protein true Inferred relationship Some
Trastuzumab emtansine Is a Immunosuppressant true Inferred relationship Some
Trastuzumab emtansine Is a Monoclonal antibody true Inferred relationship Some
Trastuzumab emtansine Is a Trastuzumab false Inferred relationship Some
Trastuzumab emtansine Has disposition Murine-human monoclonal IgG antibody false Inferred relationship Some
Trastuzumab emtansine Has disposition Immunomodulator true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab emtansine-containing product Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine only product Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine-containing product in parenteral dose form Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine only product in parenteral dose form Has active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion vial Has BoSS True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion vial Has BoSS True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for injection vial Has BoSS True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for injection vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for injection vial Has BoSS True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for injection vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial Has BoSS True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial Has precise active ingredient True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial Has BoSS True Trastuzumab emtansine Inferred relationship Some 1

Reference Sets

Substance foundation reference set

Back to Start